Search Browse Earnings

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Nasdaq:RVPH

Pharmaceutical Preparations·CUPERTINO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Bhat Laxminarayan

CFO

Narayan Prabhu

Revenue

—

Adj. EBITDA

-$39.5M

FY 2024

Net Income

-$39.3M

FY 2024

EPS (Diluted)

-$1.65

FY 2024

Stock Price

$2.42

-13.7%

2026-03-13

52W Range

$0.17 – $3.50

P/E Ratio

-1.5x

Market Cap

$279.0M

Cash

$23.4M

FY 2024

Total Debt

—

Net Cash

$23.4M

FY 2024

Enterprise Value

$255.6M

Debt / EBITDA

0.6x

FY 2024

EV / EBITDA

-6.5x

Employees

—